[3] Novakova, K., Kummer, O., Bouitbir, J., Stoffel, S
Diabetes Metabolic Syndrome Obes
Most of the US citizens opt for the GP1-1s treatment because obesity is one of the major concerns in the US, which is not easily removed through dieting or exercise
The semaglutide injection guide covers the full process from calculation through injection technique

Safe during breastfeeding Generally considered safe (but confirm with doctor): BPC-157 (healing benefits, minimal systemic effects) Topical GHK-Cu (doesn't enter bloodstream significantly) Likely safe but less data: None are extensively studied during breastfeeding Conservative approach: wait until done breastfeeding for most peptides Post-breastfeeding recovery protocol Once you've finished breastfeeding, this helps restore your body: Weeks 1-4 post-breastfeeding: BPC-157: 250mcg twice daily (gut healing, general recovery) Topical GHK-Cu (skin elasticity, stretch marks) Weeks 5+: Add CJC-1295/Ipamorelin (body recomposition, sleep quality) Add AOD 9604 or semaglutide (fat loss if needed) Expected results: Improved skin elasticity Reduced appearance of stretch marks Better body composition Restored energy levels Easier fat loss (when combined with diet/exercise) What to absolutely avoid during pregnancy and breastfeeding Never use while pregnant or breastfeeding: Semaglutide/Tirzepatide (affects nutrition to baby) Growth hormone peptides (unknown effects on development) PT-141 or sexual enhancement peptides Any systemic peptides without explicit doctor approval When in doubt: Wait
